Pila Pharma Danmark ApS Financials, key figures and credit report
Gross profit -4 798.3 kDKK FY 2025 -23% vs 2024
EBIT -4 798.3 kDKK FY 2025 -23% vs 2024
Net debt -2 315.0 kDKK FY 2025 -252.2% vs 2024
Quick ratio 3.1 FY 2025 +1.9 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -6 366.09 | -13 423.30 | -4 374.35 | -3 901.52 | -4 798.28 |
| EBIT | -6 366.09 | -13 423.30 | -4 374.35 | -3 901.52 | -4 798.28 |
| Other financial income | 46.38 | 7.01 | 9.01 | 8.99 | |
| Other financial expenses | -1.64 | -82.89 | -29.82 | -9.03 | -19.43 |
| Pre-tax profit | -6 367.73 | -13 459.81 | -4 397.15 | -3 901.54 | -4 808.72 |
| Income taxes | 1 315.40 | 2 636.41 | 579.97 | 806.88 | 1 027.83 |
| Net earnings | -5 052.32 | -10 823.40 | -3 817.18 | -3 094.66 | -3 780.90 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | 55.28 | 19.50 | 19.50 | 19.50 | |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 517.08 | 293.79 | |||
| Prepayments and accrued income | 1.73 | 4.59 | 3.83 | 15.17 | |
| Current other receivables | 13.83 | 37.03 | 238.28 | 2.33 | 470.77 |
| Current deferred tax assets | 1 315.40 | 2 636.41 | 579.97 | 810.88 | 1 027.83 |
| Short term receivables total | 1 329.24 | 2 675.17 | 1 339.93 | 1 110.83 | 1 513.77 |
| Cash and bank deposits | 131.84 | 1 408.36 | 875.50 | 994.62 | 2 314.96 |
| Cash and cash equivalents | 131.84 | 1 408.36 | 875.50 | 994.62 | 2 314.96 |
| Balance sheet total (assets) | 1 461.07 | 4 138.81 | 2 234.93 | 2 124.95 | 3 848.23 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | 6 273.83 | 13 752.34 | 5 197.58 | 3 380.40 | 6 327.10 |
| Profit of the financial year | -5 052.32 | -10 823.40 | -3 817.18 | -3 094.66 | -3 780.90 |
| Shareholders equity total | 1 271.51 | 2 978.94 | 1 430.40 | 335.74 | 2 596.21 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 47.88 | 64.23 | |||
| Current trade creditors | 1 081.93 | 697.31 | 1 437.15 | 792.86 | |
| Current owed to participating | 0.07 | ||||
| Current owed to group member | 337.21 | ||||
| Other non-interest bearing current liabilities | 189.57 | 30.06 | 42.99 | 14.77 | 459.17 |
| Current liabilities total | 189.57 | 1 159.87 | 804.52 | 1 789.21 | 1 252.03 |
| Balance sheet total (liabilities) | 1 461.07 | 4 138.81 | 2 234.93 | 2 124.95 | 3 848.23 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated